120 This may be significant in COVID-19 research because metformin, a weak mitochondria-targeting drug, has been used in COVID-19 patients.
← all excerpts
Reactive oxygen species, proinflammatory and immunosuppressive mediators induced in COVID-19: overlapping biology with cancer.
1
—
—